
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>pmid: 5694458
Clofibrate, a drug with lipid-lowering and anticoagulant properties, is being used extensively in the treatment of atherosclerosis. Few toxic effects result from regular doses in man or large amounts in animals; effects of large quantities in man are unknown. A 15-year-old boy who took 49 capsules of clofibrate is, to our knowledge, the first known instance of attempted suicide with this medication. He showed no clinical or laboratory evidence of harm from this large amount, and remained asymptomatic during the entire period of observation.
Male, Butyrates, Suicide, Cholesterol, Adolescent, Anticholesteremic Agents, Fatty Acids, Humans, Phospholipids, Triglycerides
Male, Butyrates, Suicide, Cholesterol, Adolescent, Anticholesteremic Agents, Fatty Acids, Humans, Phospholipids, Triglycerides
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
